Invasive fungal infections in critically-ill patients: A literature review and position statement from the IFI-clinical forum, Shiraz, Iran

Invasive fungal infections (IFIs) have increasingly been recognized as a serious clinical concern in critically-ill patients admitted to the intensive care units (ICUs). The most abundant pathogens in this population are Candida species. As such, a clear understanding on the epidemiology of this infection seems to be a key step in providing appropriate treatment. Expert input forums are among the practical approaches to defi ne locally-adapted clinicalpathways with regard to debated medical perspectives. To agree upon a shared approach towards IFI management in ICU, an interdisciplinary panel of experts from infectious diseases and intensive care fi elds met up in Shiraz on 28 November 2015 within the IFI-Clinical Forum (IFI-CF).This clinical forum aimed to view the available evidence, taking into consideration the recent practice guidelines on IFIs management in the ICU to arrive at an agreed position in current clinical practice. The aim of this summary is to discuss IFIs in ICU from epidemiology, the range of pathophysiology from colonization to the invasive infections, risk prediction, diagnosis and treatment perspectives.

[1]  François Gouin,et al.  Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006) , 2009, Critical care medicine.

[2]  C. Tzeng,et al.  Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[3]  P. Charles,et al.  Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study , 2009, Critical care medicine.

[4]  T. Calandra,et al.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  F. Wang,et al.  A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[6]  Joshua A. Doherty,et al.  Septic shock attributed to Candida infection: importance of empiric therapy and source control. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Xuelin Han,et al.  Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China , 2015, Clinical Oral Investigations.

[8]  C. Tascini,et al.  The definition of starting point for evaluation of timely adequate antifungal therapy , 2014, Intensive Care Medicine.

[9]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Garnacho-Montero,et al.  A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization* , 2006, Critical care medicine.

[11]  N. Demartines,et al.  Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients , 2009, Intensive Care Medicine.

[12]  A. Schuetz.  Invasive fungal infections: biomarkers and molecular approaches to diagnosis. , 2013, Clinics in laboratory medicine.

[13]  F. Zaini,et al.  In vitro Susceptibilities of Iranian Clinical non-albicans Candida species to Caspofungin and Ketoconazole , 2012 .

[14]  M. Finkelman,et al.  Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. , 2008, Journal of medical microbiology.

[15]  K. Makimura,et al.  Molecular identification and distribution profile of Candida species isolated from Iranian patients. , 2013, Medical mycology.

[16]  J. Meis,et al.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  P. Hauser,et al.  β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. , 2013, American journal of respiratory and critical care medicine.

[18]  A. Alborzi,et al.  Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study , 2011, Iranian journal of microbiology.

[19]  Jay Steingrub,et al.  International study of the prevalence and outcomes of infection in intensive care units , 2009 .

[20]  L. Leibovici,et al.  PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis , 2010, Journal of Clinical Microbiology.

[21]  M. Moghadami,et al.  Invasive Fungal Infection Prophylaxis in Immunocompromised Hosts; the Consensus from Shiraz IFI Study Group, December 2012, Shiraz, Iran , 2013 .

[22]  Victoria J. Fraser,et al.  Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality , 2005, Antimicrobial Agents and Chemotherapy.

[23]  Aseem Kumar,et al.  Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006) , 2010 .

[24]  J. Vincent,et al.  Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy , 2016, Critical Care.

[25]  A. Fothergill,et al.  Detection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS). , 2015, Medical mycology.

[26]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  F. Colardyn,et al.  Effects of nosocomial candidemia on outcomes of critically ill patients. , 2002, The American journal of medicine.

[28]  J. Rex,et al.  Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. , 2005, Medical mycology.

[29]  L. Webber,et al.  Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients , 2016, Infection and drug resistance.

[30]  J. Revelly,et al.  Preventing invasive candida infections. Where could we do better? , 2015, The Journal of hospital infection.

[31]  Yongjun Zhang,et al.  Integrated measures for prevention of invasive Candida infections in preterm infants in a Chinese neonatal intensive care unit. , 2015, American journal of infection control.

[32]  F. Şimşek,et al.  Is Timely and Appropriate Antifungal Drug Enough for Survival of Adult Cases with Candidaemia? Five-year Experience. , 2014, The West Indian medical journal.

[33]  N. Yapar.  Epidemiology and risk factors for invasive candidiasis , 2014, Therapeutics and clinical risk management.

[34]  He Huang,et al.  Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years , 2015, Journal of Zhejiang University-SCIENCE B.

[35]  P. Lipsett,et al.  The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. , 2006, Diagnostic microbiology and infectious disease.

[36]  T. Calandra,et al.  The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia , 2010, Critical care.

[37]  F. Grannis,et al.  Survival following lung resection in immunocompromised patients with pulmonary invasive fungal infection. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[38]  J. W. Pickering,et al.  Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. , 2005, Journal of clinical microbiology.

[39]  M. Martínez-Jiménez,et al.  Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment. , 2016, The Journal of antimicrobial chemotherapy.

[40]  A. Janbakhsh,et al.  Treatment of Invasive Fungal Infection: Recommendations from Scientific Leaders' Meeting on November 3rd, 2011 Tehran – Iran , 2012 .

[41]  L. Ostrosky-Zeichner,et al.  What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients , 2014, Intensive Care Medicine.

[42]  R. Rajendran,et al.  Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection—Scotland, 2012–2013 , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[43]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[44]  M. Antonelli,et al.  (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study. , 2016, The Journal of antimicrobial chemotherapy.

[45]  H. Ohge,et al.  Combined Assessment of β-d-Glucan and Degree of Candida Colonization before Starting Empiric Therapy for Candidiasis in Surgical Patients , 2004, World Journal of Surgery.

[46]  L B Reller,et al.  Duration of incubation of fungal cultures , 1996, Journal of clinical microbiology.

[47]  S. Bailly,et al.  Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients , 2015, F1000prime reports.

[48]  M. Antonelli,et al.  Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index , 2011, Critical care.

[49]  S. Abbasi,et al.  Invasive candidiasis in critical care setting, updated recommendations from "Invasive Fungal Infections-Clinical Forum", Iran. , 2014, World journal of critical care medicine.

[50]  K. Garey,et al.  Clinical Practice Patterns in Hospitalized Patients at Risk for Invasive Candidiasis , 2014, The Annals of pharmacotherapy.

[51]  M. Montagna,et al.  Candida Colonization Index in Patients Admitted to an ICU , 2011, International journal of molecular sciences.

[52]  M. Falagas,et al.  Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[53]  M. Bassetti,et al.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[54]  Liping Zhang,et al.  Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China. , 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[55]  M. Singer,et al.  Timely selection of adequate antifungal therapy for candidemia in the critically ill: don't let the yeast rise! , 2008, Critical care medicine.

[56]  Alejandro Rodríguez,et al.  Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions , 2016, Critical Care.

[57]  M. Montagna,et al.  Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project) , 2013, Infection.

[58]  T. Calandra,et al.  Bench-to-bedside review: Candida infections in the intensive care unit , 2008, Critical care.

[59]  D. Marriott,et al.  Candida Colonization as a Risk Marker for Invasive Candidiasis in Mixed Medical-Surgical Intensive Care Units: Development and Evaluation of a Simple, Standard Protocol , 2015, Journal of Clinical Microbiology.

[60]  D. Kontoyiannis.  A Clinical Perspective for the Management of Invasive Fungal Infections: Focus on IDSA Guidelines , 2001, Pharmacotherapy.

[61]  D. Andes,et al.  Fungal sepsis: optimizing antifungal therapy in the critical care setting. , 2011, Critical care clinics.

[62]  K. Carson,et al.  Utility of Measuring (1,3)-β-d-Glucan in Cerebrospinal Fluid for Diagnosis of Fungal Central Nervous System Infection , 2014, Journal of Clinical Microbiology.

[63]  M. Arendrup.  Epidemiology of invasive candidiasis , 2010, Current opinion in critical care.

[64]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  T. Staudinger,et al.  Invasive Candida infections in patients of a medical intensive care unit , 2015, Wiener klinische Wochenschrift.

[66]  R. Auckenthaler,et al.  Candida Colonization and Subsequent Infections in Critically III Surgical Patients , 1994, Annals of surgery.

[67]  David J Weber,et al.  Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[68]  F. Queiroz-Telles,et al.  Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan. , 2016, The Journal of antimicrobial chemotherapy.

[69]  A. Baronia,et al.  Risk prediction for invasive candidiasis , 2014, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[70]  Y. Skrobik,et al.  Why Candida sepsis should matter to ICU physicians. , 2013, Critical care clinics.

[71]  D. Pittet,et al.  Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[72]  A. Law,et al.  A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients. , 2010, The Journal of antimicrobial chemotherapy.

[73]  F. Guo,et al.  Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: An analysis from the China Survey of Candidiasis study. , 2015, Journal of critical care.

[74]  C. Putensen,et al.  Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis , 2008, Intensive Care Medicine.

[75]  Jacques Bille,et al.  Diagnosis of invasive candidiasis in the ICU , 2011, Annals of intensive care.

[76]  Omid Moradi Moghaddam,et al.  Invasive candidiasis in intensive care unit; consensus statement from an Iranian panel of experts, July 2013 , 2014, JRSM open.

[77]  J. Nolla,et al.  Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[78]  Xiaoying Gong,et al.  Invasive candidiasis in intensive care units in China: Risk factors and prognoses of Candida albicans and non-albicans Candida infections. , 2016, American journal of infection control.

[79]  A. Korur,et al.  Active Invasive Fungal Infection in a Patient With Severe Aplastic Anemia. , 2016, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.